Enzyme Immunoassay for the determination of human Carcino Embryonic Antigen (CEA) in serum, plasma, cell culture supernatant and other biological samples. For research use only, not for use in diagnostic procedures.
Carcinoembryonic antigen (CEA) is a glycoprotein with a molecular weight of 200 kDa and is normally derived from embryonic endodermal epithelium in the fetus, controlled by fetal oncogenes. CEA is closely associated with various functions of endothelial cells, including adhesion, proliferation, and migration of cells both in vivo and in vitro . It is present on the endoluminal side of the cell membrane of normal cells and is thought to inhibit apoptosis and hence is involved in tumor pathogenesis.
- Assay Description:
- 90 min (37°C) + 60 min (37°C) + 30 min (37°C) + 10-20 min (37°C) = 3 hour 20 min Total Incubation Time
- Catalog number:
- IB08209
- configuration:
- Reagents sufficient for 96 determinations
- controls:
- None Provided
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- For research use only, not for use in diagnostic procedures
- Protocol:
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- MSDS:
- Available Upon Request
- Other names:
- Carcino Embryonic Antigen (CEA)
- Sample types:
- Serum, plasma, cell culture supernatant and other biological samples
- Sample volume:
- 100 μL / determination
- standards:
- 8 calibrators prepared from one lyophilized stock
- Standard range:
- 0 / 0.156 ng/mL - 10 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 0.094 ng/mL
- Species:
- Human
